Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 185 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA) Greece
Ireland
Israel
Poland
Portugal
Romania
Russia
South Korea
Taiwan
United States
View All

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

Atypical Hemolytic Uremic Syndrome Phase3 Austria
Brazil
China
Czechia
Greece
India
Japan
Slovakia
Slovenia
South Korea
Taiwan
United Kingdom
United States
View All

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Moderate-to-severe Plaque Psoriasis Russia

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis Phase3 Argentina
Austria
Belgium
Brazil
Bulgaria
Chile
China
Colombia
Croatia
Denmark
Georgia
Guatemala
Hong Kong
India
Ireland
Israel
Italy
Jordan
Latvia
Lebanon
Lithuania
Malaysia
Mexico
Netherlands
Poland
Saudi Arabia
Slovakia
Spain
Switzerland
Taiwan
Turkey (Türkiye)
United Arab Emirates
United Kingdom
United States
View All

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Plaque, Atherosclerotic Phase4 China

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Sjögrens Disease, Systemic Lupus Erythematosus, Rheumatoid Arthritis Phase2 Argentina
Canada
Hungary
Italy
Poland
Spain
United States
View All

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Asthma Phase3 Argentina
Austria
Bulgaria
Colombia
Czechia
Greece
Guatemala
Hungary
Italy
Mexico
Panama
Portugal
Romania
South Africa
Spain
Vietnam
View All

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

Multiple Sclerosis, Relapsing-Remitting Italy

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Fascioliasis Phase4 Colombia
Egypt
Peru
Turkey (Türkiye)
Vietnam
View All

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

Severe Malaria Phase2 Burkina Faso
Congo, The Democratic Republic of the
Côte D'Ivoire
Gabon
Kenya
Mozambique
Nigeria
Rwanda
Uganda
View All